BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4035256)

  • 1. [New proposals for the treatment of multiple sclerosis. Preliminary study].
    Floris V; Spadaro M
    Riv Neurol; 1985; 55(3):169-84. PubMed ID: 4035256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary reports on a therapeutical trial in multiple sclerosis.
    Floris V; Spadaro M; Tilia G
    Riv Neurol; 1987; 57(3):185-8. PubMed ID: 3313667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms.
    Hellwig K; Stein FJ; Przuntek H; Müller T
    BMC Neurol; 2004 Nov; 4(1):18. PubMed ID: 15530171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary results of imurek treatment of multiple sclerosis].
    Müller J; Kreiner R; Sauermann W
    Psychiatr Neurol Med Psychol (Leipz); 1976 Dec; 28(12):755-61. PubMed ID: 1019278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of mitoxantrone and intrathecal triamcinolone acetonide treatment in chronic progressive multiple sclerosis patients.
    Hellwig K; Schimrigk S; Lukas C; Hoffmann V; Brune N; Przuntek H; Müller T
    Clin Neuropharmacol; 2006; 29(5):286-91. PubMed ID: 16960474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with triamcinolone acetonide during pregnancy.
    Dombrowski MP; Brown CL; Berry SM
    J Matern Fetal Med; 1996; 5(6):310-3. PubMed ID: 8972405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging.
    Massacesi L; Parigi A; Barilaro A; Repice AM; Pellicanò G; Konze A; Siracusa G; Taiuti R; Amaducci L
    Arch Neurol; 2005 Dec; 62(12):1843-7. PubMed ID: 16344342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary evaluation of azathioprine (Imuran) in the treatment of multiple sclerosis.
    Tucker WG; Kapphahn KH
    Henry Ford Hosp Med J; 1969; 17(2):89-92. PubMed ID: 5783817
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2007 Aug; 259(1-2):95-103. PubMed ID: 17507031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitis.
    Schuttelaar ML; Coenraads PJ
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1076-82. PubMed ID: 18384552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis.
    Welch MJ; Bronsky E; Findlay S; Pearlman DS; Southern DL; Storms WW; Weakley S
    Clin Ther; 1994; 16(2):253-62. PubMed ID: 8062320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
    Gorouhi F; Solhpour A; Beitollahi JM; Afshar S; Davari P; Hashemi P; Nassiri Kashani M; Firooz A
    J Am Acad Dermatol; 2007 Nov; 57(5):806-13. PubMed ID: 17658663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.